FREQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
FREQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Frequency Therapeutics's Net Income (Continuing Operations) for the three months ended in Jun. 2023 was $-10.80 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2023 was $-67.25 Mil.
The historical data trend for Frequency Therapeutics's Net Income (Continuing Operations) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frequency Therapeutics Annual Data | |||||||||||||||
Trend | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | |||||||||
Net Income (Continuing Operations) | Get a 7-Day Free Trial | -19.17 | -18.75 | -26.51 | -84.69 | -81.58 |
Frequency Therapeutics Quarterly Data | ||||||||||||||||||||
Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | |
Net Income (Continuing Operations) | Get a 7-Day Free Trial | -21.29 | -19.55 | -17.36 | -19.54 | -10.80 |
Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.
Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-67.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frequency Therapeutics (NAS:FREQ) Net Income (Continuing Operations) Explanation
Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.
Thank you for viewing the detailed overview of Frequency Therapeutics's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.
Richard J. Mitrano | officer: VP Finance & Operations | C/O FREQUENCY THERAPEUTICS, INC., 19 PRESIDENTIAL WAY, 2ND FLOOR, WOBURN MA 01801 |
David L. Lucchino | director, officer: President and CEO | C/O FREQUENCY THERAPEUTICS, INC., 19 PRESIDENTIAL WAY, 2ND FLOOR, WOBURN MA 01801 |
Christopher R. Loose | officer: Chief Scientific Officer | C/O FREQUENCY THERAPEUTICS, INC., 19 PRESIDENTIAL WAY, 2ND FLOOR, WOBURN MA 01801 |
Quentin Mccubbin | officer: Chief Manufacturing Officer | C/O FREQUENCY THERAPEUTICS, INC., 10 PRESIDENTIAL WAY, 2ND FLOOR, WOBURN MA 01801 |
Wendy S Arnold | officer: Chief People Officer | 19 PRESIDENTIAL WAY, SUITE 203, WOBURN MA 01801 |
Carl Lebel | officer: Chief Development Officer | 23256 MARIPOSA DE ORO, MALIBU CA 90265 |
Peter P. Pfreundschuh | officer: Chief Financial Officer | C/O IMMUNOMEDICS, INC., 300 THE AMERICAN ROAD, MORRIS PLAINS NJ 07950 |
Michael Bookman | officer: General Counsel and Secretary | C/O FREQUENCY THERAPEUTICS, INC., 10 PRESIDENTIAL WAY, 2ND FLOOR, WOBURN MA 01801 |
Joel S Marcus | director, 10 percent owner | C/O ALEXANDRIA REAL ESTATE EQUITIES, INC, 26 NORTH EUCLID AVENUE, PASADENA CA 91101 |
Cynthia L Feldmann | director | 17 WINTHROP ROAD, WAYLAND MA 01778 |
Marc A Cohen | director | 1000 WILSON BLVD. #1800, ARLINGTON VA 22209 |
James E Flynn | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Deerfield Partners, L.p. | 10 percent owner, other: Possible Member of 10% Group | 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010 |
Robert Langer | director | 98 MONTVALE RD, NEWTON MA 02459 |
Alexandria Venture Investments, Llc | 10 percent owner | 26 NORTH EUCLID AVENUE, PASADENA CA 91101 |
From GuruFocus
By Business Wire Business Wire • 04-22-2022
By PRNewswire • 07-26-2023
By Business Wire Business Wire • 02-27-2023
By Business Wire Business Wire • 01-04-2022
By Business Wire Business Wire • 05-18-2022
By Business Wire • 07-14-2023
By Business Wire Business Wire • 02-28-2022
By Business Wire • 08-10-2023
By Business Wire Business Wire • 12-19-2022
By PRNewswire • 08-08-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.